Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Prednisolone; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Biomarker; Therapeutic Use
- 04 Nov 2020 Biomarkers information updated
- 06 Sep 2012 Planned number of patients changed from 170 to 523 as reported by ClinicalTrials.gov.
- 06 Sep 2012 Planned number of patients changed from 170 to 523 as reported by ClinicalTrials.gov.